A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that ...
Atrasentan received FDA approval for IgA nephropathy, reducing proteinuria by 36% and showing consistent efficacy across diverse patient groups. Value-based care programs significantly slowed CKD ...
The number of New Jerseyans suffering from a gradual decline in their kidney function is increasing, with more Black residents having worse outcomes, said a new report released Wednesday, Dec. 10. The ...
A phase 2 trial suggests that a drug commonly used for constipation may help preserve kidney function in people with moderate to severe chronic kidney disease by reshaping the gut microbiome and ...
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past? A healthy ...
Please provide your email address to receive an email when new articles are posted on . The global age-standardized CKD prevalence rate rose by 3.5% in 1990 to 14.2%. Kidney dysfunction was the ...
Chronic kidney disease has surged to nearly 800 million cases and is now among the top causes of death worldwide. The condition is heavily linked to diabetes, hypertension, and obesity, and often goes ...
MONTREAL--(BUSINESS WIRE)--A new analysis from the Global Burden of Disease Study published in The Lancet in November 2025 1, shows that the impact of chronic kidney disease (CKD) has substantially ...
On the first day of ASN 2025 Kidney Week, Dr Sumeska Thavarajah reports on several clinical trials in kidney disease that were presented, notably including a phase 2 study of rilparencel, a stem cell ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So that's one of our big focuses, and also, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results